// App-Quantinova.ai

1596 : Trends in Inpatient Chemotherapy Hospitalizations, Cost and Mortality for Patients with Hematological Malignancies: Insights from the National Inpatient Sample

Researchers

Presenter

  • Ghulam Rehman Mohyuddin

Principal Investigators

  • Kellen Gil

  • Brian McClune

  • Nausheen Ahmed

  • Al-Ola Abdallah

  • Siddhartha Ganguly

  • Joseph P. McGuirk

  • Leyla Shune

  • Saqib Abbasi

Medical Centers

  • Kansas University Medical Center, Overland Park, KS

  • Kansas University Medical Center, Kansas City, KS

  • University of Utah, Salt Lake City, UT

  • Kansas University Medical Center, Kansas City, KS

  • University of Kansas Medical Center, Westwood, KS

  • University of Kansas Health System, Kansas City, KS

  • Department of Hematologic Malignancies and Cellular Therapeutics,University of Kansas Medical Center,Kansas City, KS,Stati Uniti

  • Department of Hematologic Malignancies and Cellular Therapeutics,University of Kansas Medical Center,Kansas City, KS,Stati Uniti

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Hematological malignancies

  • Acute lymphoblastic leukemia

  • Acute myelocytic leukemia

  • Multiple Myeloma

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A